€300 million boost for biomedicine in Berlin
26 November 2012
Two of Berlin's largest biomedical research centres are
merging to form the Berlin Institute of Health (BHI), a joint venture
that will receive at least €300 million in new funding over the next
This makes Berlin an even more significant and attractive research
site, not only in the field of biomedicine. This is happening at the
right time, according to Germany Trade & Invest, for an aging
demographic means that there is an increasing demand for healthcare
products and services.
"The BHI will make Berlin one of the world's top sites for
medical excellence and will attract the world's best scientists and
junior doctors. The partnership between the Berlin state and federal
government has created an exemplary model of cooperation between
university and non-university research. Germany has a globally
recognized biomedical sector, and it will only improve due to the
Institute's innovative models to train medical talent," said Dr.
Sandra Bütow, chemical and health expert at Germany Trade & Invest.
Germany Trade & Invest is the foreign trade and inward investment
agency of the Federal Republic of Germany.
Germany is renowned for its effective public-private partnerships
such as the Central Innovation Program SME, a country-wide support
measure that provides sustainable support to the innovative
capabilities and competiveness of small- and medium-sized
enterprises. Participants include businesses and researchers from
the health and wellness industry who collaborate in order to find
innovative and value-added healthcare solutions.